UK Markets closed

Global Lancets Market to Reach $5.5 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Lancets estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$5. 5 Billion by 2027, growing at a CAGR of 4.

New York, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lancets Industry" - https://www.reportlinker.com/p06032024/?utm_source=GNW
8% over the analysis period 2020-2027. Safety, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Standard segment is readjusted to a revised 3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 8.5% CAGR

The Lancets market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$758.4 Million by the year 2027.



Specialty Segment to Record 5.9% CAGR

In the global Specialty segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6.5% CAGR through the analysis period.

Select Competitors (Total 36 Featured) -
Arkray
B. Braun Melsungen
Becton, Dickinson and Company
HTL-Strefa S.A
Owen Mumford
Roche Diagnostics
Sarstedt
Sterilance Medical (Suzhou)
Terumo Corporation
Ypsomed


Read the full report: https://www.reportlinker.com/p06032024/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Lancets - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Blood
Glucose Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Blood Glucose Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Blood Glucose Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Hemoglobin Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Hemoglobin Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Hemoglobin Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Cholesterol Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Cholesterol Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Cholesterol Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Coagulation Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Coagulation Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Coagulation Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Home
Care by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Home Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Home Care by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Lancets Market Analysis of Annual Sales in US$
Million for Years 2012 through 2027

Table 26: World Recent Past, Current & Future Analysis for
Lancets by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 27: World Historic Review for Lancets by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 28: World 15-Year Perspective for Lancets by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2012, 2021 & 2027

Table 29: World Recent Past, Current & Future Analysis for
Safety by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 30: World Historic Review for Safety by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 31: World 15-Year Perspective for Safety by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 32: World Recent Past, Current & Future Analysis for
Standard by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 33: World Historic Review for Standard by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 34: World 15-Year Perspective for Standard by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 35: World Recent Past, Current & Future Analysis for
Specialty by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 36: World Historic Review for Specialty by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 37: World 15-Year Perspective for Specialty by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2022 (E)
Table 38: USA Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 39: USA Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 40: USA 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose Testing,
Hemoglobin Testing, Cholesterol Testing, Coagulation Testing
and Other Applications for the Years 2012, 2021 & 2027

Table 41: USA Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 42: USA Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: USA 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 44: USA Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 45: USA Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 46: USA 15-Year Perspective for Lancets by Product Type -
Percentage Breakdown of Value Sales for Safety, Standard and
Specialty for the Years 2012, 2021 & 2027

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: Canada Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 49: Canada 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 50: Canada Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 51: Canada Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 52: Canada 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 53: Canada Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 54: Canada Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 55: Canada 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

JAPAN
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2022 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 57: Japan Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 58: Japan 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 59: Japan Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 60: Japan Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 61: Japan 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 62: Japan Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 63: Japan Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 64: Japan 15-Year Perspective for Lancets by Product Type -
Percentage Breakdown of Value Sales for Safety, Standard and
Specialty for the Years 2012, 2021 & 2027

CHINA
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2022 (E)
Table 65: China Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 66: China Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 67: China 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 68: China Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 69: China Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 70: China 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 71: China Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 72: China Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 73: China 15-Year Perspective for Lancets by Product Type -
Percentage Breakdown of Value Sales for Safety, Standard and
Specialty for the Years 2012, 2021 & 2027

EUROPE
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2022 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 75: Europe Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 76: Europe 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 77: Europe Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 78: Europe Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 79: Europe 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 80: Europe Recent Past, Current & Future Analysis for
Lancets by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 81: Europe Historic Review for Lancets by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 82: Europe 15-Year Perspective for Lancets by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2012, 2021 & 2027

Table 83: Europe Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 84: Europe Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 85: Europe 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

FRANCE
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2022 (E)
Table 86: France Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 87: France Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: France 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 89: France Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 90: France Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 91: France 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 92: France Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 93: France Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 94: France 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

GERMANY
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2022 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 96: Germany Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 97: Germany 15-Year Perspective for Lancets by
Application - Percentage Breakdown of Value Sales for Blood
Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications for the Years 2012,
2021 & 2027

Table 98: Germany Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 99: Germany Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 100: Germany 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 101: Germany Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 102: Germany Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 103: Germany 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 105: Italy Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 106: Italy 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 107: Italy Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 108: Italy Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 109: Italy 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 110: Italy Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 111: Italy Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 112: Italy 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

UNITED KINGDOM
Lancets Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2022 (E)
Table 113: UK Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 114: UK Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 115: UK 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose Testing,
Hemoglobin Testing, Cholesterol Testing, Coagulation Testing
and Other Applications for the Years 2012, 2021 & 2027

Table 116: UK Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 117: UK Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 118: UK 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 119: UK Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 120: UK Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 121: UK 15-Year Perspective for Lancets by Product Type -
Percentage Breakdown of Value Sales for Safety, Standard and
Specialty for the Years 2012, 2021 & 2027

SPAIN
Table 122: Spain Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin
Testing, Cholesterol Testing, Coagulation Testing and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 123: Spain Historic Review for Lancets by Application -
Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing,
Coagulation Testing and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 124: Spain 15-Year Perspective for Lancets by Application -
Percentage Breakdown of Value Sales for Blood Glucose
Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation
Testing and Other Applications for the Years 2012, 2021 & 2027

Table 125: Spain Recent Past, Current & Future Analysis for
Lancets by End-Use - Home Care, Other End-Uses and Hospitals &
Clinics - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 126: Spain Historic Review for Lancets by End-Use - Home
Care, Other End-Uses and Hospitals & Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 127: Spain 15-Year Perspective for Lancets by End-Use -
Percentage Breakdown of Value Sales for Home Care, Other
End-Uses and Hospitals & Clinics for the Years 2012, 2021 &
2027

Table 128: Spain Recent Past, Current & Future Analysis for
Lancets by Product Type - Safety, Standard and Specialty -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 129: Spain Historic Review for Lancets by Product Type -
Safety, Standard and Specialty Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 130: Spain 15-Year Perspective for Lancets by Product
Type - Percentage Breakdown of Value Sales for Safety, Standard
and Specialty for the Years 2012, 2021 & 2027

RUSSIA
Table 131: Russia Recent Past, Current & Future Analysis for
Lancets by Application - Blood Glucose Testing, Hemoglobin

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032024/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001